Fig. 1From: MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1MiR-186, MDR1 and GST-π expression in ovarian cancer cell lines. Results of the RT-PCR showed (a) lower miR-186 expression level in A2780/DDP and A2780/Taxol than in A2780, (b) while higher MDR1 and (c) GST-π mRNA expression level in A2780/DDP and A2780/Taxol than in A2780. d MiR-186 transfection significantly induced miR-186 expression. Results are representative of three separate experiments. Data are expressed as the mean ± standard deviation. * P < 0.05Back to article page